Biotechs Pressured Following Clinton Tweet (IBB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Biotechs Pressured Following Clinton Tweet (IBB)
September 21, 2015 1:57 PM EDT
BMO Capital analyst Alex Arfaei weighed in on Valeant Pharmaceuticals (NYSE: VRX) which is down 6% in response to a Tweet from Hillary Clinton referring to this article in the... More
September 21, 2015 1:19 PM EDT
(Updated - September 21, 2015 1:29 PM EDT)
Biotech stocks bounced off lows Monday afternoon, paring declines that were largely driven by fears of increased government regulation of drug pricing. The source of concern was a tweet by presidential candidate Hillary Clinton... More
September 21, 2015 1:13 PM EDT
Cowen reiterated an Outperform rating and $125.00 price target on Gilead Sciences (NASDAQ: GILD) following the release top-line data from the Ph. III ASTRAL trials of SOF+VEL.
Analyst Phil Nadeau commented, "GILD released top-line data from the Ph. III ASTRAL trials of... More
